EPC 2019 Updates in Pulmonary Disease
Didactic lectures allow the speakers to provide evidence based medical recommendations, updates and expert opinion.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology and the Eastern Pulmonary Conference. The American College of Allergy, Asthma and Immunology is accredited by the ACCME to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists, pulmonologists and allied healthcare professionals in the field of allergy, asthma and immunology.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the cellular and cytokine mechanisms that occur with Th1 driven inflammation and the diseases associated with this form of adaptive immunity, highlighting sarcoidiosis.
- Outline how to make proper choices for the patient with uncontrolled asthma by identifying asthma phenotypes and using biomarkers to choose biologic therapy that addresses the underlying asthma endotype.
- Discuss how to control the over-utilization of tests, treatments, and procedures in hospitalized patients in ICU settings and how to efficiently oxygenate and monitor unstable patients outside the ICU in anticipation of clinical deterioration
- Outline the approach to weaning from mechanical ventilation and how to control spontaneous patient efforts that may be deleterious
- Describe the clinical consequences of being at high altitude and how to prevent or treat them.
- Explain the clinical presentations, treatments and outcomes of interstitial lung diseases including IPF and NSIP.
- Discuss the clinical presentations, testing and radiographic assessment of the various forms of pulmonary vasculitis and how to approach treatment of these diseases
- Explain how “real life studies” can augment results of randomized control trials.
- Outline the recent advances the radiographic assessment of airway disease.
- Apply current evidence-based practices to escalate and de-escalate therapy for COPD including how to use eosinophil counts and measures of atopy to help with these decisions.
- Discuss how “GOLD 0” patients can be identified and why it is important to do so.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 14.25 AMA PRA Category 1 Credit™
- 14.25 Attendance